A long-awaited media mega deal finally got the green light today, and the fallout rippled across an entire industry.
Meanwhile, a quiet sentiment gauge that Wall Street actually pays attention to just hit a level it has not seen in years. There is a sharper story buried in these numbers than the closing tally admits.
Five Stocks Screened (Sponsored)
After analyzing thousands of companies, our analysts pinpointed the 5 Stocks Set to Double based on accelerating performance, improving fundamentals, and strong technical signals.
This newly released report explains why these five could be positioned for major moves in the year ahead.
While results aren’t guaranteed, previous reports uncovered gains as high as +175%, +498%, and +673%.
Access the free report before midnight.
See the 5 Stocks Set to Double
*Results may not represent all stock picks and may reflect partially closed positions. Investing involves risk, and past performance does not guarantee future results. This is not financial advice.
Markets
A federal judge signed off on Paramount’s settlement with a dozen state attorneys general today, clearing the final roadblock to its 81 billion dollar acquisition of Warner Bros.
Discovery and sending Netflix and Disney shares lower on competitive jitters. Bank of America’s sell-side indicator, a contrarian gauge of Wall Street bullishness, climbed to its highest reading since March 2022, the same month the Fed started its last hiking cycle.
Fed Vice Chair Philip Jefferson echoed earlier comments that the central bank can afford to wait before raising rates again, even as the 10-year Treasury yield whipsawed between a fresh multidecade high and a sharp afternoon reversal. Accenture jumped on strong AI-driven client demand. Plenty to chew on tonight.
DJIA: [+0.04%]
S&P 500: [+0.19%]
Nasdaq: [+0.04%]
Russell 2000: [+0.46%]
Market-Moving News
Semiconductors & AI
Broadcom is deepening its financial and commercial ties with Anthropic after agreeing to lend the AI developer up to $42 billion, while Anthropic is expected to become Broadcom’s largest chip-design customer next year.
Synopsys is strengthening its position in AI-assisted chip design through new partnerships with OpenAI and Amazon, including a specialized GPT-Synopsys model and a licensing agreement worth more than $1 billion with AWS.
Nuclear Energy & Fuel
Constellation Energy secured long-term backing for a major Maryland nuclear expansion after Amazon signed a 20-year power agreement, supporting more than $3 billion of plant improvements and 190 megawatts of new generating capacity.
NANO Nuclear Energy is moving deeper into the domestic fuel supply chain through an agreement to acquire NRC-licensed processing assets from Radnostix, adding infrastructure for potential uranium deconversion and other fuel-cycle activities.
Space & Satellite Communications
Rocket Lab secured its largest commercial launch contract after Synspective ordered 20 additional Electron missions, expanding a radar satellite network designed to image any location worldwide within hours under almost any weather conditions.
America’s three largest wireless carriers are building a shared satellite strategy after appointing Paul Roth interim CEO of their new joint venture, which aims to eliminate mobile dead zones and improve connectivity during natural disasters.
Seven Stocks Selected (Sponsored)
Only a small percentage of stocks meet the criteria for this report.
Zacks analysts just released a new list of 7 stocks selected using multiple indicators for the next 30 days.
Recent picks have produced notable short-term gains, though results can vary.
See the 7 Stocks Selected for the Next 30 Days
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
Biotech & Drug Development
Nektar Therapeutics reported durable hair regrowth from its experimental alopecia treatment after data showed many responders maintained at least 80% scalp coverage for months after completing therapy, supporting the case for less-frequent dosing.
Foghorn Therapeutics is cutting roughly 40% of its workforce after ending its cancer collaboration with Eli Lilly, as early-stage results for FHD-909 failed to show enough benefit to justify expanding the clinical program.
Autos & Transportation
General Motors reported a 5.5% decline in third-quarter U.S. sales after total vehicle deliveries fell to 670,974 units from 710,347 a year earlier, as high gasoline prices weighed on demand and affordability concerns pressured the broader new-vehicle market.
Lyft agreed to pay $272.5 million to settle California driver wage claims after the state and three major cities accused it of misclassifying drivers as independent contractors, resolving allegations involving unpaid wages, benefits, and other worker protections.
Top Winners and Losers
Nexalin Technology [NXL] $7.55 (+76.40%)
Nexalin jumped after bringing on a new global commercial advisor to help push its neurostimulation device into wider markets, the kind of hire that signals a company getting serious about actually selling its technology rather than just developing it.
Investors in small medtech names love seeing a real go-to-market plan take shape. This looks like one of those moments.
Republic Power Group [RPGL] $26.20 (+59.85%)
Republic Power Group just kept climbing, even piling on gains after news broke of a fresh 20-cent share sale filing that would normally spook a stock through dilution fears.
Instead, traders shrugged it off and kept buying, still riding the momentum from last week’s reverse split reset. Sometimes a hot stock just refuses to read its own bad news.
Armada Acquisition Corp. II [XRPN] $23.43 (+42.87%)
Shareholders officially approved Armada’s merger with Evernorth Holdings today, locking in its transformation into a dedicated XRP treasury vehicle with roughly 300 million dollars in expected gross cash.
This is the moment the speculation became official business. With the deal now sealed, this stock trades on Ripple’s fortunes about as directly as anything on the exchange.
Corteva [CTVA] $12.57 (-83.81%)
Corteva’s eye-popping drop looks scarier than it is, since today marked the official spinoff of its seed business into the newly independent Vylor, which mechanically strips a huge chunk of value out of the parent’s share price.
Layer on a fresh 455 million dollar PFAS settlement weighing on sentiment, and investors had plenty to digest beyond just the math.
VerifyMe [OPNW] $5.54 (-38.31%)
VerifyMe began trading under its new OPNW ticker today after completing its merger with OpenWorld, officially rebranding into a tokenization platform for real-world assets.
Fresh tickers after a business combination tend to bring exactly this kind of turbulence as old shareholders and new believers fight it out over what the stock should actually be worth. Today the sellers won that argument.
Nektar Therapeutics [NKTR] $46.99 (-22.39%)
Nektar is having its worst session in more than three years after mid-stage data on its hair loss drug rezpegaldesleukin came in softer than hoped for patients with alopecia areata.
Even a Jefferies analyst defending the durability of the results could not stop the bleeding today. Biotech investors have a short memory for context when a headline number disappoints.
A stock rallies hard in the final 10 minutes on heavy volume. Do you trust the move, or assume it's index rebalancing noise?
Dollar Power Fades (Sponsored)
November 1910. Seven of America's most powerful bankers met in secret on Jekyll Island, Georgia, to design the Federal Reserve.
Since 1913, the dollar has lost over 96% of its purchasing power.
Tan Gera, CFA©, an ex-Wall Street banker, warns CBDCs could be the next step: every transaction tracked, every account programmable.
His free presentation shows investors with $50k+ how decentralized finance offers a way out.
Watch it here
*This content is for educational purposes only. The opinions expressed are from DM Intelligence LLC, doing business as Decentralized Masters, who are not licensed financial advisors or registered investment advisors. The reader acknowledges that DM Intelligence LLC is not responsible for any losses, direct or indirect, resulting from the use of this information, including errors, omissions, or inaccuracies.
*Results are not typical and will vary. Success with digital currencies requires time, effort, and involves substantial risk including total loss of investment. Past performance does not indicate future results. All investments are at your own risk.
*Please click here if you would like to unsubscribe.
Everything Else
💎 The next wave of market leaders is already forming and seven stocks are quietly doing what the Mag 7 did early on
⚖️ Florida sued Pfizer over claims related to the safety of its COVID-19 vaccine, opening a new legal battle over how the company represented the shot.
💾 Nvidia’s strategy of using its chips to help finance the AI boom is facing a Wall Street reality check, as lenders scrutinize the risks behind increasingly complex AI infrastructure deals.
📈 Wall Street turned slightly higher as the bond rally gathered momentum, helping stocks overcome some pressure from oil prices that remained elevated.
💰 Broadcom is set to lend Anthropic up to $42 billion to lease its chips, creating a massive financing arrangement tied directly to the AI company’s computing needs.
🛒 Walmart is using light-up digital shelf labels to make products easier to find, helping both shoppers and employees locate items faster across its stores.
You Read This Far. Here's Where the Real Work Lives.
We run three live portfolios on Autopilot, and everything about them is public: every position, every allocation, every trade, visible the moment it happens.
We keep our own money in each one, because analysis you won't fund yourself is just content.
THE UNBREAKABLE STACK
Our growth book: durable software and cybersecurity names built to compound quietly for years.
THE HORMUZ PREMIUM
Our energy thesis: built for how that sector actually pays, over quarters, not headlines.
THE ELON INDEX
Our conviction bet on the Musk universe: Tesla, and the companies orbiting his ventures, energy, AI, infrastructure. High-beta by design, for investors who want direct exposure to the trade rather than watching it from the sidelines.
And here's the part that makes it effortless: Autopilot does the trading for you. Connect the brokerage you already use (Robinhood, Schwab, Fidelity, and more) and every move we make gets mirrored in your own account automatically.
Your money never leaves your brokerage. It stays in your account, under your control, and you can override any trade or disconnect anytime. Autopilot even rebalances automatically when allocations drift, and you get a notification every time something happens.
No watching tickers. No timing entries. No fat-finger mistakes at market open. You pick the portfolio, we do the work, your account follows along.
Pick the one that fits your risk level, or run all three:
Live portfolios, real positions, our own capital at stake. Your funds stay in your own brokerage account. Past performance doesn't guarantee future results.
That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!
Thanks for reading. I'll see you at the next open!
Best Regards,
— Adam G.
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
